ARVO 2019 Part 1 – The data, the disease and the developments
Part 1 on the Annual Association for Research in Vision & Ophthalmology (ARVO) . The latest findings in Myopia control, management & treatment.
Part 1 on the Annual Association for Research in Vision & Ophthalmology (ARVO) . The latest findings in Myopia control, management & treatment.
Welcome to Part 2 of the ARVO 2019 Research Roundup! For article abstracts and more info, please click on the headings.
This is Part 3 on the Annual Association for Research in Vision and Ophthalmology 2019 (ARVO) conference summary.
There’s a little more to think about in the important role spectacle lenses play in myopia management. Even if we prescribe contact lenses, our young myopes are most likely to need a back up spectacle lens option. Children prescribed atropine will need the best spectacle lens prescribed for them to minimise the impact of any side effects.
Are progressive addition lenses and bifocals created equal for myopia control? When do they work and when do spectacles have minimal efficacy? How should we pick which lens type to prescribe, and what’s on the horizon for our non-contact lens wearing young myopes?
This article provides insights into identifying the pre-myope, identifying the myopia progressor & effective management strategies.
In May 2019 the professional journal Contact Lens Spectrum published my bi-annual ‘Refractive Focus’ column, entitled ‘An Ode to my Retinoscope’.
The landmark International Myopia Institute (IMI) White paper reports were published on 28 February 2019. As lead author on the Clinical Management Guidelines paper, I was thrilled to see the work of my 13 co-authors and I shared with a keen clinician audience worldwide.
Discover part 2 of the latest news from the biennial Orthokeratology Society of Oceania (OSO) conference 2018.
Discover the highlights from the biennial Orthokeratology Society of Oceania conference covering OrthoK and myopia control research and practice.